Christophe Van Huffel Email & Phone Number
Who is Christophe Van Huffel? Overview
A concise factual answer block for searchers comparing this professional profile.
Christophe Van Huffel is listed as CSO and co-founder - OncoRNA at OncoRNA, based in Rixensart, Walloon Region, Belgium. AeroLeads shows a matched LinkedIn profile for Christophe Van Huffel.
Christophe Van Huffel previously worked as Co-Founder and CSO at Oncorna and GENERGON - Management Company at Genergon. Christophe Van Huffel holds Doctor Of Philosophy - Phd, Chemistry from Université Libre De Bruxelles.
Email format at OncoRNA
This section adds company-level context without repeating Christophe Van Huffel's masked contact details.
Review company-level records connected to Christophe Van Huffel before choosing the right outreach path.
About Christophe Van Huffel
We are excited to announce that OncoRNA has been selected as a direct partner in the Med4Cure EU program. This prestigious selection allows us to access up to €30.42M in non-dilutive funding.Our mission of OncoRNA is to manufacture and commercialize Personalized RNA Cancer Immuno-Therapy (PRCIT) potentially a fast, high-performant, and cost-effective personalized immunotherapies for cancer patients. We have developed a novel approach to personalised oncology vaccines. Our unique technology offers significant advantages over existing methods, including the ability to encode over 100 individualized neoantigens simultaneously in a single tube. This eliminates the need for a narrow selection of antigens and allows for a three-week turnaround time from tumor biopsy to personalized vaccine. Additionally, our process is cost-effective and well-suited for automation.We have demonstrated the production process, shown antigen expression in mice, and are moving toward IND. We have also secured the necessary agreements and partnerships for clinical production and trials.
Listed skills include Biotechnology, Lifesciences, Molecular Biology, Genomics, and 20 others.
Christophe Van Huffel's current company
Company context helps verify the profile and gives searchers a useful next step.
Christophe Van Huffel work experience
A career timeline built from the work history available for this profile.
Genergon - Management Company
CurrentGENERGON supports Biotechs, Pharma and Clinical Trials Services Companies with General Management, Business Development, international growth and strategies optimisation.
North-American Pharma Business Prospection
Business Growth Adviser
Interim Ceo - Short Term Mission
Bioprocess Department Director - Short Term Mission
Lab management of Accelerator Development Service (PD) projects for Gene Therapy and Virus manufacturing.
Ceo
Capital increase with a new partner "MRC Technology", a British medical research charity.
University Spin-Off Coach
Management of IP of the University of Liège by licensing to existing companies or through new spin-offs, companies.
Program Manager
Investment Specialist - Intern
DRI Capital, through its managed funds, has purchased over 60 royalty streams from some of the world’s leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. As a result of these transactions, DRI Capital, through its managed funds, owns royalties on some of the best-selling biopharmaceutical products in the.
Director R&D
Eppendorf Array Technologies is a DNA and protein microarray research, development and production site in Belgium. EAT is part of the Eppendorf AG group (Hamburg)
Analyst - Biotechnology
Coverage Europe's public genomics companies - DeCode Genetics, MWG Biotech, Genset.
Chief Scientist
Genomics Department, Managing the genomics activities of the life science group.
Scientist
Genomics Department. Oncology program (Eli Lillly)Millennium Predictive Medicine
Postdoctoral Fellow
Bruce Beutler won the 2011 Nobel Prize in Physiology or Medicine for work carried at the Howard Hughes Medical Institute(HHMI). The project was based on technology expertise acquired during my Ph.D. and introduced in Bruce Beutler's Lab.
Christophe Van Huffel education
Doctor Of Philosophy - Phd, Chemistry
Cepac
Master'S Degree, Chemistry
Scientific
Fundamental
Frequently asked questions about Christophe Van Huffel
Quick answers generated from the profile data available on this page.
What company does Christophe Van Huffel work for?
Christophe Van Huffel works for OncoRNA.
What is Christophe Van Huffel's role at OncoRNA?
Christophe Van Huffel is listed as CSO and co-founder - OncoRNA at OncoRNA.
Where is Christophe Van Huffel based?
Christophe Van Huffel is based in Rixensart, Walloon Region, Belgium while working with OncoRNA.
What companies has Christophe Van Huffel worked for?
Christophe Van Huffel has worked for Oncorna, Genergon, Oncodna, The Cancer Theranostic Company, Myneo, and Persomed Life Sciences.
How can I contact Christophe Van Huffel?
You can use AeroLeads to view verified contact signals for Christophe Van Huffel at OncoRNA, including work email, phone, and LinkedIn data when available.
What schools did Christophe Van Huffel attend?
Christophe Van Huffel holds Doctor Of Philosophy - Phd, Chemistry from Université Libre De Bruxelles.
What skills is Christophe Van Huffel known for?
Christophe Van Huffel is listed with skills including Biotechnology, Lifesciences, Molecular Biology, Genomics, Life Sciences, Business Strategy, Bioinformatics, and Oncology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Christophe Van Huffel you were looking for.
View similar profiles